Room program summary: Stream 1 / Poster session

24.03.2021
09:00–09:15 Welcome note
09:15–10:50 Plenary session 1
Viral evolution and function
11:00–12:30 Workshop 1
Adaptive immunity
12:50–14:20 BioNTech
The mRNA platforms against mutating SARS-CoV-2
14:35–17:05 Plenary session 2
SARS-CoV-2 – Vaccines and neutralising abs
17:20–18:05 Poster session 1
Adaptive immunity
18:05–18:50 Poster session 1
Innate immunity
19:00–20:30 Workshop 4
Innate immunity
25.03.2021
08:00–09:30 Workshop 7
Intrinsic antiviral defenses
09:45–11:00 Plenary session 3
New emerging viruses – Pathomechanisms and replication
12:15–12:45 LI-COR Biosciences GmbH
Reliable Westerns are going viral – About In-Cell WesternsTM and faster virus characterisation
12:45–13:15 AID Autoimmun Diagnostika GmbH
Did we bark up the wrong tree for too long? Challenges for immunomonitoring of emerging diseases as a sum of all parts to result in a whole
13:30–15:00 Workshop 10
Clinical virology I
15:15–16:00 Poster session 2
Clinical virology I
16:00–16:45 Poster session 2
Intrinsic antiviral defenses
17:00–18:15 Plenary session 4
Immune Response to SARS-CoV-2
18:30–19:30 GfV General assembly
26.03.2021
08:30–10:00 Workshop 13
Clinical virology II
10:15–11:45 Workshop 16
Viral replication I
11:50–12:05 BAG Diagnostics GmbH
Potential of the ViroQ® real-time PCR kits in context of the pandemic of SARS-CoV-2
12:15–13:15 Takara Bio Europe SAS
Detect, Decipher and Decide! Takara Bio’s Tools for Optimal Viral Surveillance.
13:30–14:15 Poster session 3
Clinical virology II
14:15–15:00 Poster session 3
Viral replication I
15:15–16:45 Plenary session 5
Systems approaches in virology and drug discovery
17:00–18:30 Loeffler-Frosch award and lectures
18:30–18:45 Farewell
19:30–21:00 Panel discussion
Public panel discussion